Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Alkermes Plc (NQ: ALKS )

21.47 USD -0.82 (-3.68%)
Official Closing Price Updated: 5:05 PM EST, Jan 21, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Alkermes Plc

< Previous 1 2
...
16 17 18 19 20 21 22 23 Next >
Investors Review: Alkermes Plc (NASDAQ:ALKS), Qiagen NV (NASDAQ:QGEN), Neustar Inc (NYSE:NSR)
Lakeway, TX -- (SBWIRE) -- 02/22/2013 -- vb-news.net, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following... 
From SBWire - Latest Press Releases
Drug Delivery Stocks Mostly Lower (Hospira, Alkermes Plc, pSivida Corp, Flamel Technologies S.A)
Houston, TX -- (SBWIRE) -- 02/21/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com... 
From SBWire - Latest Press Releases
Alkermes’ Corporate Presentation to be Webcast at Three Upcoming Conferences
From Business Wire News Releases
Free Research Report on Perusahaan Perseroan P.T. Telekomunikasi Indonesia, Alkermes plc, Mine Safety Appliances Co., Microsemi Corp. and Magellan Health Services, Inc.
From Marketwired News Releases
Drug Stocks Alert (CIGNA Corporation, Perrigo Company, Illumina, Alkermes Plc)
Houston, TX -- (SBWIRE) -- 02/13/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com... 
From SBWire - Latest Press Releases
Alkermes’ Corporate Presentation to be Webcast at Two Upcoming Conferences
From Business Wire News Releases
Tellabs, Inc. (NASDAQ:TLAB) Slumps on Earnings CLSN, ALKS, NIM, TLAB)
Lakeway, NY -- (SBWIRE) -- 02/01/2013 -- Celsion Corporation (NASDAQ:CLSN) stock decreased 13.91% to $1.28 after the company yesterday announced that ThermoDox® in combination with radiofrequency... 
From SBWire - Latest Press Releases
Elan Sells Its Remaining Stake in Alkermes
From Business Wire News Releases
Alkermes plc Reports Third Quarter Fiscal 2013 Financial Results
From Business Wire News Releases
Alkermes to Host Conference Call to Discuss Financial Results for Third Quarter of Fiscal 2013
From Business Wire News Releases
Alkermes Announces Notice of Allowance of Key U.S. Patent for Aripiprazole Lauroxil, a New Schizophrenia Drug Candidate
From Business Wire News Releases
Alkermes Expands CNS Pipeline and Announces Positive Results from Phase 1 Study of ALKS 3831, a Novel Antipsychotic Therapy for the Treatment of Schizophrenia
From Business Wire News Releases
Alkermes’ Corporate Presentation to be Webcast at the 31st Annual J.P. Morgan Healthcare Conference
From Business Wire News Releases
Alkermes and Collaborators to Present Data from Three Ongoing Clinical Development Programs at Two Major Medical Meetings
From Business Wire News Releases
Alkermes’ Corporate Presentation to be Webcast at Two Upcoming Conferences
From Business Wire News Releases
Alkermes plc Reports Second Quarter Fiscal 2013 Financial Results
From Business Wire News Releases
Alkermes to Host Conference Call to Discuss Financial Results for Second Quarter of Fiscal 2013
From Business Wire News Releases
Alkermes plc Closes Debt Refinancing, Lowering Interest Rate and Reducing Principal Amount
From Business Wire News Releases
Are These Stocks a Buy or Sell? ( PPHM, LEN, ALKS, BGS )
Los Angelas, CA -- (SBWIRE) -- 09/24/2012 -- HotPennyStockNews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks.... 
From SBWire - Latest Press Releases
Alkermes plc Announces Pricing of New Term Loans
From Business Wire News Releases
Alkermes’ Corporate Presentation to Be Webcast at Two Upcoming Conferences
From Business Wire News Releases
Alkermes plc Reports First Quarter Fiscal 2013 Financial Results
From Business Wire News Releases
Alkermes to Host Conference Call to Discuss Financial Results for First Quarter of Fiscal 2013
From Business Wire News Releases
INVEGA® SUSTENNA® Three-Month Formulation of Paliperidone Palmitate Enters Phase 3 Clinical Program for Schizophrenia
From Business Wire News Releases
Once-Weekly BYDUREON™ Provided Greater Glucose Control, Weight Loss and Lower Risk of Hypoglycemia Compared to Once- or Twice-Daily Levemir® in Type 2 Diabetes
From Business Wire News Releases
BYDUREON™ Was Associated with Significant and Sustained Glycemic Control at Four Years
From Business Wire News Releases
BYDUREON™ Improved A1C, Fasting Glucose, Pulse Pressure and Weight Regardless of Baseline Body Weight in Patients with Type 2 Diabetes
From Business Wire News Releases
Alkermes’ Corporate Presentation to be Webcast at Two Upcoming Conferences
From Business Wire News Releases
Alkermes Announces Results from Phase 2 Study of ALKS 37 for Treatment of Opioid-Induced Constipation
From Business Wire News Releases
Alkermes Presents Positive Clinical Data of ALKS 5461 at 52nd Annual New Clinical Drug Evaluation Unit Meeting
From Business Wire News Releases
< Previous 1 2
...
16 17 18 19 20 21 22 23 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.